188 related articles for article (PubMed ID: 17426705)
1. In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol.
Chander SK; Foster PA; Leese MP; Newman SP; Potter BV; Purohit A; Reed MJ
Br J Cancer; 2007 May; 96(9):1368-76. PubMed ID: 17426705
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents.
Ireson CR; Chander SK; Purohit A; Perera S; Newman SP; Parish D; Leese MP; Smith AC; Potter BV; Reed MJ
Br J Cancer; 2004 Feb; 90(4):932-7. PubMed ID: 14970876
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition of multi-drug-resistant breast cancer cells by 2-methoxyoestradiol-bis-sulphamate and 2-ethyloestradiol-bis-sulphamate.
Suzuki RN; Newman SP; Purohit A; Leese MP; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):269-78. PubMed ID: 12711013
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamate.
Raobaikady B; Purohit A; Chander SK; Woo LW; Leese MP; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):351-8. PubMed ID: 12711022
[TBL] [Abstract][Full Text] [Related]
5. The effects of 2-methoxyoestrogen sulphamates on the in vitro and in vivo proliferation of breast cancer cells.
Utsumi T; Leese MP; Chander SK; Gaukroger K; Purohit A; Newman SP; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):219-27. PubMed ID: 15862969
[TBL] [Abstract][Full Text] [Related]
6. The effects of 2-methoxy oestrogens and their sulphamoylated derivatives in conjunction with TNF-alpha on endothelial and fibroblast cell growth, morphology and apoptosis.
Ho YT; Newman SP; Purohit A; Leese MP; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 2003 Aug; 86(2):189-96. PubMed ID: 14568571
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of MDA-MB-231 cell cycle progression and cell proliferation by C-2-substituted oestradiol mono- and bis-3-O-sulphamates.
Raobaikady B; Reed MJ; Leese MP; Potter BV; Purohit A
Int J Cancer; 2005 Oct; 117(1):150-9. PubMed ID: 15880363
[TBL] [Abstract][Full Text] [Related]
8. 2-MeOE2bisMATE induces caspase-dependent apoptosis in CAL51 breast cancer cells and overcomes resistance to TRAIL via cooperative activation of caspases.
Wood L; Leese MP; Mouzakiti A; Purohit A; Potter BV; Reed MJ; Packham G
Apoptosis; 2004 May; 9(3):323-32. PubMed ID: 15258464
[TBL] [Abstract][Full Text] [Related]
9. The in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancer.
Parsons MF; Foster PA; Chander SK; Jhalli R; Newman SP; Leese MP; Potter BV; Purohit A; Reed MJ
Br J Cancer; 2008 Nov; 99(9):1433-41. PubMed ID: 18841154
[TBL] [Abstract][Full Text] [Related]
10. Effect of nitroxoline on angiogenesis and growth of human bladder cancer.
Shim JS; Matsui Y; Bhat S; Nacev BA; Xu J; Bhang HE; Dhara S; Han KC; Chong CR; Pomper MG; So A; Liu JO
J Natl Cancer Inst; 2010 Dec; 102(24):1855-73. PubMed ID: 21088277
[TBL] [Abstract][Full Text] [Related]
11. 2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique.
Foster PA; Ho YT; Newman SP; Kasprzyk PG; Leese MP; Potter BV; Reed MJ; Purohit A
Breast Cancer Res Treat; 2008 Sep; 111(2):251-60. PubMed ID: 17957467
[TBL] [Abstract][Full Text] [Related]
12. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression.
Salcedo R; Ponce ML; Young HA; Wasserman K; Ward JM; Kleinman HK; Oppenheim JJ; Murphy WJ
Blood; 2000 Jul; 96(1):34-40. PubMed ID: 10891427
[TBL] [Abstract][Full Text] [Related]
13. Role of human cripto-1 in tumor angiogenesis.
Bianco C; Strizzi L; Ebert A; Chang C; Rehman A; Normanno N; Guedez L; Salloum R; Ginsburg E; Sun Y; Khan N; Hirota M; Wallace-Jones B; Wechselberger C; Vonderhaar BK; Tosato G; Stetler-Stevenson WG; Sanicola M; Salomon DS
J Natl Cancer Inst; 2005 Jan; 97(2):132-41. PubMed ID: 15657343
[TBL] [Abstract][Full Text] [Related]
14. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
[TBL] [Abstract][Full Text] [Related]
15. Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitors.
Patel RR; Sengupta S; Kim HR; Klein-Szanto AJ; Pyle JR; Zhu F; Li T; Ross EA; Oseni S; Fargnoli J; Jordan VC
Eur J Cancer; 2010 Jun; 46(9):1537-53. PubMed ID: 20303261
[TBL] [Abstract][Full Text] [Related]
16. The suppression of fibroblast growth factor 2/fibroblast growth factor 4-dependent tumour angiogenesis and growth by the anti-growth factor activity of dextran derivative (CMDB7).
Bagheri-Yarmand R; Kourbali Y; Mabilat C; Morère JF; Martin A; Lu H; Soria C; Jozefonvicz J; Crépin M
Br J Cancer; 1998 Jul; 78(1):111-8. PubMed ID: 9662260
[TBL] [Abstract][Full Text] [Related]
17. 2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer.
Tagg SL; Foster PA; Leese MP; Potter BV; Reed MJ; Purohit A; Newman SP
Br J Cancer; 2008 Dec; 99(11):1842-8. PubMed ID: 18985042
[TBL] [Abstract][Full Text] [Related]
18. Effects of tamoxifen and interferon-beta or the combination on tumor-induced angiogenesis.
Lindner DJ; Borden EC
Int J Cancer; 1997 May; 71(3):456-61. PubMed ID: 9139884
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of angiogenesis as an explanation of Matrigel-enhanced tumorigenicity.
Bonfil RD; Vinyals A; Bustuoabad OD; Llorens A; Benavides FJ; Gonzalez-Garrigues M; Fabra A
Int J Cancer; 1994 Jul; 58(2):233-9. PubMed ID: 7517919
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center.
Hotchkiss KA; Ashton AW; Mahmood R; Russell RG; Sparano JA; Schwartz EL
Mol Cancer Ther; 2002 Nov; 1(13):1191-200. PubMed ID: 12479700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
